AstraZeneca Looks To Challenge GSK’s Nucala With Fasenra EGPA Data

Head-To-Head Trial Of The Two IL-5 Inhibitors

 
• By Kevin Grogan
  
Race_Horse
AstraZeneca goes head-to-head with GSK in EPGA • Source: Shutterstock

More from Respiratory

More from Therapy Areas